Prospeo
Hero Section BackgroundHero Section Background
Gain Therapeutics

Gain Therapeutics

Biotechnology ResearchFlag of USBethesda, Maryland, United States21-50 Employees

Company overview

Headquarters4800 Montgomery Ln, Suite 220, Bethesda, Maryland 20814, US
Phone number+13015001556
Website
NAICS541714
Keywords
Oncology, Rare Diseases, Neurodegenerative Diseases, Pharmacological Chaperones, Lysosomal Storage Disorders
Founded2017
Employees21-50
Socials

Key Contacts at Gain Therapeutics

Flag of US

Gwen Melincoff

Member Board Of Directors

Flag of US

Gene Mack

Chief Executive Officer

Flag of ES

Rinaldo Wander Montalvão

Director Of Artificial Intelligence

Flag of US

Roshan Ahmed

Senior Director, Business Development

Flag of IT

Alberto Bretoni

Finance Director

Gain Therapeutics Email Formats

Gain Therapeutics uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@gaintherapeutics.com), used 52.2% of the time.

FormatExamplePercentage
{first name}{last name}
johndoe@gaintherapeutics.com
52.2%
{first initial}{last name}
jdoe@gaintherapeutics.com
47.8%

About Gain Therapeutics

Gain Therapeutics, Inc. is a clinical-stage biotechnology company leading the discovery and development of next generation allosteric therapies. Gain’s lead drug candidate, GT-02287 is currently being evaluated for the treatment of Parkinson’s disease with or without a GBA1 mutation. Results from a Phase 1 study of GT-02287 in healthy volunteers demonstrated favorable safety and tolerability, plasma exposure in the projected therapeutic range, CNS exposure, and target engagement and modulation of GCase enzyme. Gain’s unique approach enables the discovery of novel, allosteric small molecule modulators that can restore or disrupt protein function. Deploying its highly advanced Magellan™ platform, Gain is accelerating drug discovery and unlocking novel disease-modifying treatments for untreatable or difficult-to-treat disorders including neurodegenerative diseases, rare genetic disorders and oncology.

$

Gain Therapeutics revenue & valuation

Annual revenue$55,180
Revenue per employee$2,000
Estimated valuation?$176,576
Total funding$17,100,000

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry
Director
Vice President

Employees by Department

Gain Therapeutics has 13 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore Gain Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2023-12-2414$10,100,000
2025-08-1614$7,000,000

Funding Insights

$17,100,000

Total funding amount

$7,000,000

Most recent funding amount

2

Number of funding rounds

Gain Therapeutics Tech Stack

Discover the technologies and tools that power Gain Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Joomla

Joomla

CMS

reCAPTCHA

reCAPTCHA

Security

WP Rocket

WP Rocket

Caching

iubenda

iubenda

Cookie compliance

Animate.css

Animate.css

UI frameworks

Elementor

Elementor

Page builders

Microsoft 365

Microsoft 365

Email

Cloudflare

Cloudflare

CDN

Yoast SEO Premium

Yoast SEO Premium

SEO

HTTP/3

HTTP/3

Miscellaneous

PHP

PHP

Programming languages

WordPress

WordPress

Blogs

Frequently asked questions

Gain Therapeutics is located in Bethesda, Maryland, US.
You can reach Gain Therapeutics at +13015001556.
Gain Therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.
Gain Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.
Gain Therapeutics has raised a total of $17,100,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles